These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30257412)

  • 1. MiR-1284 enhances sensitivity of cervical cancer cells to cisplatin via downregulating HMGB1.
    Chen J; Li G
    Biomed Pharmacother; 2018 Nov; 107():997-1003. PubMed ID: 30257412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-142 inhibits the development of cervical cancer by targeting HMGB1.
    Jiang D; Wang H; Li Z; Li Z; Chen X; Cai H
    Oncotarget; 2017 Jan; 8(3):4001-4007. PubMed ID: 27829233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2.
    Xu ZH; Yao TZ; Liu W
    Biomed Pharmacother; 2018 Nov; 107():1410-1417. PubMed ID: 30257357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
    Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
    Feng LL; Shen FR; Zhou JH; Chen YG
    Gene; 2019 May; 696():105-112. PubMed ID: 30738960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0001589/miR-1248/HMGB1 axis enhances EMT-mediated metastasis and cisplatin resistance in cervical cancer.
    Ma T; Guo J; Han J; Li L; Ren Y; Huang J; Diao G; Zheng X; Zheng Y
    Mol Carcinog; 2023 Nov; 62(11):1645-1658. PubMed ID: 37431919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway.
    Wang Y; Shang G; Wang W; Qiu E; Pei Y; Zhang X
    Life Sci; 2020 Sep; 256():117967. PubMed ID: 32553931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
    Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
    Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-144 reverses cisplatin resistance in cervical cancer via targeting LHX2.
    Shi F; Su J; Liu Z; Wang J; Wang T
    J Cell Biochem; 2019 Sep; 120(9):15018-15026. PubMed ID: 31017720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1.
    Li X; Li Y; Han Y; Dong B; Liu D; Che L; Liu Y; Wang Y
    Cancer Biother Radiopharm; 2020 Jun; 35(5):338-344. PubMed ID: 32379984
    [No Abstract]   [Full Text] [Related]  

  • 12. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
    Zhang WY; Liu YJ; He Y; Chen P
    J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Tumour Biol; 2016 Oct; 37(10):13155-13166. PubMed ID: 27456356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.
    Yang F; Guo L; Cao Y; Li S; Li J; Liu M
    Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21.
    Yao T; Lu R; Zhang J; Fang X; Fan L; Huang C; Lin R; Lin Z
    J Cell Physiol; 2019 Jun; 234(6):9605-9615. PubMed ID: 30352127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1.
    He X; Xiao X; Dong L; Wan N; Zhou Z; Deng H; Zhang X
    Tumour Biol; 2015 Mar; 36(3):2065-75. PubMed ID: 25394901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
    Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer.
    Li J; Ping Z; Ning H
    Int J Mol Sci; 2012 Nov; 13(12):16053-64. PubMed ID: 23443110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer.
    Zhang T; Zou P; Wang T; Xiang J; Cheng J; Chen D; Zhou J
    Tumour Biol; 2016 Jul; 37(7):8931-40. PubMed ID: 26753959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.